These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28614005)

  • 1. PREVALENCE AND CORRELATES OF ADHERENCE IN CHILDREN AND ADOLESCENTS TREATED WITH GROWTH HORMONE: A MULTICENTER ITALIAN STUDY.
    Bagnasco F; Di Iorgi N; Roveda A; Gallizia A; Haupt R; Maghnie M;
    Endocr Pract; 2017 Aug; 23(8):929-941. PubMed ID: 28614005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R; Nicolino M; Cammas B; de Buyst V; Tauber M; Hamel JF
    Front Endocrinol (Lausanne); 2021; 12():790169. PubMed ID: 35126310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in adherence to rhGH treatment: Socioeconomic causes and effect on children's growth.
    De Pedro S; Murillo M; Salinas I; Granada ML; Martinez M; Puig-Domingo M; Andreu A; Bel J
    Growth Horm IGF Res; 2016 Feb; 26():32-5. PubMed ID: 26774403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review.
    Gomez R; Ahmed SF; Maghnie M; Li D; Tanaka T; Miller BS
    Front Endocrinol (Lausanne); 2022; 13():795224. PubMed ID: 35299969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.
    Assefi A; van Dommelen P; Arnaud L; Otero C; Fernandez-Luque L; Koledova E; Calliari LE
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e32626. PubMed ID: 35049518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial patient choice of a growth hormone device improves child and adolescent adherence to and therapeutic effects of growth hormone replacement therapy.
    Gau M; Takasawa K
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):989-993. PubMed ID: 28771439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone.
    Cappa M; Maghnie M; Carbone V; Chioma L; Errichiello C; Giavoli C; Giordano M; Guazzarotti L; Klain A; Montini G; Murer L; Parpagnoli M; Pecoraro C; Pesce S; Verrina E
    Front Endocrinol (Lausanne); 2020; 11():587. PubMed ID: 33013690
    [No Abstract]   [Full Text] [Related]  

  • 10. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report.
    Akchurin OM; Kogon AJ; Kumar J; Sethna CB; Hammad HT; Christos PJ; Mahan JD; Greenbaum LA; Woroniecki R
    BMC Nephrol; 2017 May; 18(1):181. PubMed ID: 28558814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to growth hormone therapy in children and its potential barriers.
    Mohseni S; Heydari Z; Qorbani M; Radfar M
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):13-20. PubMed ID: 29216008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
    Root AW; Kemp SF; Rundle AC; Dana K; Attie KM
    J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication adherence and growth in children with CKD.
    Akchurin OM; Schneider MF; Mulqueen L; Brooks ER; Langman CB; Greenbaum LA; Furth SL; Moxey-Mims M; Warady BA; Kaskel FJ; Skversky AL
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1519-25. PubMed ID: 24970873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency.
    Mancini A; Vergani E; Bruno C; Giavoli C; Spaziani M; Isidori AM; Arosio M; Pontecorvi A
    Front Endocrinol (Lausanne); 2023; 14():1298775. PubMed ID: 38027149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.
    Poyrazoğlu Ş; Akçay T; Arslanoğlu İ; Atabek ME; Atay Z; Berberoğlu M; Bereket A; Bideci A; Bircan İ; Böber E; Can Ş; Cesur Y; Darcan Ş; Demir K; Dündar B; Ersoy B; Esen İ; Güven A; Kara C; Keskin M; Kurtoğlu S; Memioğlu N; Özbek MN; Özgen T; Sarı E; Şıklar Z; Şimşek E; Turan S; Yeşilkaya E; Yüksel B; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):37-44. PubMed ID: 25800474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone.
    Massa G; Vanderschueren-Lodeweyckx M; Bouillon R
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):137-42. PubMed ID: 8435894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients.
    Kappelgaard AM; Mikkelsen S; Knudsen TK; Fuchs GS
    J Pediatr Endocrinol Metab; 2011; 24(7-8):489-96. PubMed ID: 21932587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact.
    Orso M; Polistena B; Granato S; Novelli G; Di Virgilio R; La Torre D; d'Angela D; Spandonaro F
    PLoS One; 2022; 17(2):e0264403. PubMed ID: 35213607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.